Literature DB >> 7295792

The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts.

F Roerdink, J Dijkstra, G Hartman, B Bolscher, G Scherphof.   

Abstract

125I-labeled albumin or poly(vinyl pyrrolidone) encapsulated in intermediate size multilamellar or unilamellar liposomes with 30-40% of cholesterol were injected intravenously into rats. In other experiments liposomes containing phosphatidyl[Me-14C]choline was injected. 1 h after injection parenchymal or non-parenchymal cells were isolated. Non-parenchymal cells were separated by elutriation centrifugation into a Kupffer cell fraction and an endothelial cell fraction. From the measurements of radioactivities in the various cell fractions it was concluded that the liposomes are almost exclusively taken up by the Kupffer cells. Endothelial cells did not contribute at all and hepatocytes only to a very low extent to total hepatic uptake of the 125I-labels. Of the 14C-label, which orginates from the phosphatidylcholine moiety of the liposomes, much larger proportions were recovered in the hepatocytes. A time-dependence study suggested that besides the involvement of phosphatidylcholine exchange between liposomes and high density lipoprotein, a process of intercellular transfer of lipid label from Kupffer cells to the hepatocytes may be involved in this phenomenon. Lanthanum or gadolinium salts, which effectively block Kupffer cell activity, failed to accomplish an increase in the fraction of liposomal material recovered in the parenchymal cells. This is compatible with the notion that liposomes of the type used in these experiments have no, or at most very limited, access to the liver parenchyma following their intravenous administration to rats.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295792     DOI: 10.1016/0304-4165(81)90148-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

2.  Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase.

Authors:  N Bergeron; L Kotite; M Verges; P Blanche; R L Hamilton; R M Krauss; A Bensadoun; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.

Authors:  J A Kamps; H W Morselt; P J Swart; D K Meijer; G L Scherphof
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis.

Authors:  K J Williams; S Vallabhajosula; I U Rahman; T M Donnelly; T S Parker; M Weinrauch; S J Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

Review 6.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

7.  Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine.

Authors:  P Harvie; A Désormeaux; M C Bergeron; M Tremblay; D Beauchamp; L Poulin; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 8.  Liposomes in treatment of infectious diseases.

Authors:  F Emmen; G Storm
Journal:  Pharm Weekbl Sci       Date:  1987-06-19

9.  Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene.

Authors:  P Soriano; J Dijkstra; A Legrand; H Spanjer; D Londos-Gagliardi; F Roerdink; G Scherphof; C Nicolau
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink
Journal:  Infection       Date:  1988       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.